Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4644-4651
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4644
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4644
Table 3 Significant associations of baseline factors with baseline hepatic hepatitis B virus covalently closed-circular DNA in univariate linear regression analysis
| Estimate1 | 95%CI | P value | |
| Baseline serum HBV DNA, per 1 log10 IU/mL | 0.11 | 0.08, 0.13 | < 0.0001 |
| Baseline total hepatic HBV DNA, per 1 log10 IU/mL | 0.11 | 0.07, 0.16 | < 0.0001 |
| HBV genotype F: Not F | -0.41 | -0.67, -0.15 | 0.0023 |
- Citation: Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World J Gastroenterol 2015; 21(15): 4644-4651
- URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4644.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i15.4644